At least three additional U.S. states pass veteran-specific ibogaine access legislation by end of 2027

Texas already passed a law letting veterans use ibogaine outside clinical trials. Veterans are a sympathetic group, and states are willing to pass right-to-try laws giving people access to unproven treatments. But ibogaine causes serious heart problems, and state legislators will worry about liability — if someone dies from a heart attack after ibogaine their state approved, who gets sued? That worry will slow things down. Probably only three more states will do this by 2027.

As of 2026-04-29, Texas has passed veteran ibogaine legislation. The prediction requires three *additional* states. State right-to-try precedents and bipartisan veteran sympathy are genuine tailwinds. However, ibogaine's cardiac risk profile creates a substantive barrier to state legislators — medical liability exposure from state-sanctioned access to a cardiotoxic substance is non-trivial and will slow adoption. Cannabis right-to-try analogy is partially valid but cannabis lacks ibogaine's acute mortality risk, which complicates the legislative template. Three states in under two years is achievable but not certain. Confidence reduced from 0.76 to 0.62.